DALACIN C PHOSPHATE 2ML Ireland - English - HPRA (Health Products Regulatory Authority)

dalacin c phosphate 2ml

pharmacia ireland - clindamycin phosphate - concentrate for soln for inf - 150

DALACIN C PHOSPHATE 4ML Ireland - English - HPRA (Health Products Regulatory Authority)

dalacin c phosphate 4ml

pharmacia ireland - clindamycin phosphate - concentrate for soln for inf - 150

DOBUTAMINE-HAMELN 250 MG/ 5 ML AMPOULE Ireland - English - HPRA (Health Products Regulatory Authority)

dobutamine-hameln 250 mg/ 5 ml ampoule

hameln pharmaceuticals gmbh - dobutamine hydrochloride - concentrate for soln for inf - 50 mg/ml

DOBUTAMINE-HAMELN 250 MG/ 50 ML VIAL Ireland - English - HPRA (Health Products Regulatory Authority)

dobutamine-hameln 250 mg/ 50 ml vial

hameln pharmaceuticals gmbh - dobutamine hydrochloride - solution for infusion - 5 mg/ml

DOBUTAMINE-HAMELN 250 MG/20 ML AMPOULE Ireland - English - HPRA (Health Products Regulatory Authority)

dobutamine-hameln 250 mg/20 ml ampoule

hameln pharmaceuticals gmbh - dobutamine hydrochloride - concentrate for soln for inf - 12.5 mg/ml

DOBUTAMINE-HAMELN 250 MG/50 ML AMPOULE Ireland - English - HPRA (Health Products Regulatory Authority)

dobutamine-hameln 250 mg/50 ml ampoule

hameln pharmaceuticals gmbh - dobutamine hydrochloride - solution for infusion - 5 mg/ml

calcium gluconate Australia - English - Department of Health (Therapeutic Goods Administration)

calcium gluconate

orion laboratories pty ltd t/a perrigo australia - calcium gluconate -

DBL CLINDAMYCIN INJECTION Australia - English - Department of Health (Therapeutic Goods Administration)

dbl clindamycin injection

hospira australia pty ltd - clindamycin phosphate -

Tobra-day Australia - English - Department of Health (Therapeutic Goods Administration)

tobra-day

phebra pty ltd - tobramycin sulfate -

DALACIN C clindamycin 600 mg/4 mL (as phosphate) injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

dalacin c clindamycin 600 mg/4 ml (as phosphate) injection ampoule

pfizer australia pty ltd - clindamycin phosphate, quantity: 0 qs (equivalent: clindamycin, qty 150 mg/ml) - injection, solution - excipient ingredients: water for injections; benzyl alcohol; sodium hydroxide; disodium edetate; hydrochloric acid - indications as at 20 june 2005 : dalacin c phosphate is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. dalacin c phosphate is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci and staphylococci. its use should be reserved for penicillin - allergic patients or other patients for whom, in the judgement of the physician, a penicillin is inappropriate. anaerobes - serious respiratory tract infections such as empyema, anaerobic pneumonitis and lung abscess; serious skin and skin structure infections; septicaemia; intra-abdominal infections such as peritonitis and intra-abdominal abscess (typically resulting from anaerobic organisms resident in the normal gastrointestinal tract); infections of the female pelvis and genital tract such as endometritis, non-gonococcal tubo-ovarian abscess, pelvic cellulitis and post-surgical vaginal cuff infection, all when given in conjunction with an antibiotic of appropriate gram